Home > WJCD>
Biography


Dr. Gen-Min Lin

Medicine Department

Hualien-Armed Forces General Hospital, Chinese Taipei


E-mail: farmer507@yahoo.com.tw


Qualifications


2010-2012 Postgraduate education, Tzu-Chi University, Master of Public health (MPH)
2007-2009 Cardiovascular Disease, Clinical practice:Tri-Service General Hospital, Taipei, Taiwan

2003-2006 Internal medicine, Clinical practice:Tri-Service General Hospital, Taipei, Taiwan
1996-2003 National Defense Medical Center, Taipei, Taiwan: Bechelor degree of Medicine, (MD)


Publications (Selected)

  1. Lin WY, Lin GM, Wu CC*. Coexistence of non-communicated chylothorax and chylous ascites in nephrotic syndrome. Nephrology (Carlton). 2009 Oct;14(7):700. (Case Report) (SCI)
  2. Kan LP, Chu KM, Lin GM*. Letter by Kan et al regarding article. “Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.”Circulation. 2009 Nov;120:e164. (Letter) (SCI, *corresponding author)
  3. Lin GM, Sun LW, Lin CS, Chu KM, Tzeng BH*. Effects of Coronary Intervention on Cardiopulmonary Exercise Testing in Men with Stable Coronary Artery Disease – A Pilot Observation. Acta Cardiologica Sinica 2009 Dec; 25:190-200(Original article) (SCI)
  4. Chou CH, Lin GM, Ku CH, Chang FY*. Comparison of APACHE II, GCS and MRC in predicting outcomes in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2010 Jan; 14: 86-92 (Original article) (SCI)
  5. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article. “Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.” Circulation. 2010 Mar;121:e43. (Letter) (SCI, *corresponding author)
  6. Lin GM*, Han CL. The loading dose of clopidogrel in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty. Am J Emerg Med. 2010 Mar;28:382-3 (Letter) (SCI, *corresponding author)
  7. Lin GM*, Han CL. Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials. Eur Heart J. 2010 Mar; 31:753-4. (Letter) (SCI, *corresponding author)
  8. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article. “Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population.”Circulation. 2010 Jun 22;121(24):e450 (letter) (SCI, *corresponding author)
  9. Lin GM*, Chu KM, Han CL. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Am Heart J. 2010 Sep;160(3):e21 (letter) (SCI, *corresponding author)
  10. Lin GM*, Han CL. Letter regarding bradyarrhythmia caused by ginseng in a patient with chronic kidney disease. Am J Emerg Med. 2010 Oct;28(8):978 (letter) (SCI, *corresponding author)
  11. Lin GM*, Chu KM, Han CL. Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models. Int J Cardiol. 2011 Feb 3;146(3):422-3. (SCI, *corresponding author)
  12. Lin GM*, Chu KM, Han CL. The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortality. Int J Cardiol. 2011 Feb 3;146(3):431. (SCI, *corresponding author)
  13. Lin GM*, Chu KM, Han CL. Elective intra-aortic balloon pump placement in high-risk percutaneous coronary intervention. JAMA. 2010 Nov 24;304(20):2240 (SCI, *corresponding author)
  14. Lin GM*, Chu KM, Han CL. Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors. Int J Cardiol. 2011;146(2):280-2. (SCI, *corresponding author)
  15. Lin GM*, Han CL.Letter regarding rapidly improving, severe acute myocarditis after a scorpion bite. Am J Emerg Med. 2011;29(3):346-7 (SCI, *corresponding author)
  16. Lin GM*, Li YH, Wen SH, Chen SY, Chu KM, Han CL. Predictors, moderators and mediators for the effectiveness of pexelizumab treatment in patients undergoing primary coronary revascularization. Int J Cardiol. 2011; 147(2):340-1. (SCI, *corresponding author)
  17. Chen YG, Lin TY, Lin GM, Lin JC. Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine. Respir Care. 2011; 56(3):339-41 (SCI)
  18. Lin GM*, Li YH, Chu KM, Han CL. A single level of plasma troponin-I predicts left ventricular remodelling after primary angioplasty. Heart. 2011;97(4):340-1 (SCI, *corresponding author)
  19. Lin GM*, Li YH, Han CL. Letter for Killip classification and glucose level in patients with acute myocardial infarction. Am J Emerg Med. 2011; 29(4):462 (SCI, *corresponding author)
  20. Lin GM*, Li YH. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2011;107(4):641. (SCI, *corresponding author)
  21. Lin GM*, Li YH. Usefulness of serial of B-type natriuretic peptide and troponin-I levels to predict left ventricular remodeling after primary coronary angioplasty.Am J Cardiol. 2011;107(5):797-8. (SCI, *corresponding author)
  22. Lin GM*, Li YH, Wen SH. Aerobic and resistance training for patients with type 2 diabetes. JAMA. 2011; 305(9):891 (SCI, *corresponding author)
  23. Lin GM*, Chu KM, Han CL. Letter by Lin et al regarding article, "Acute kidney injury and cardiovascular outcomes in acute severe hypertension". Circulation. 2011;123(9):e267 (SCI, *corresponding author)
  24. Lin GM*, Li YH, Chu KM, Han CL. What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease? Int J Cardiol. 2011 Jun 16;149(3):387 (SCI, *corresponding author)
  25. Lin GM*, Li YH, Chu KM, Han CL. Hyponatremia may reflect malnutrition in patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2011;183(6):827 (SCI, *corresponding author)
  26. Lin GM*, Li YH, Chu KM, Han CL. Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy. Am Heart J. 2011;161(4):e17 (SCI, *corresponding author)
  27. Lin GM*, Li YH, Chu KM, Han CL. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Am Heart J. 2011;161(4):e21 (SCI, *corresponding author)
  28. Lin GM*,Chu KM, Han CL. Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease". Stroke. 2011 Jun;42(6):e389 (SCI, *corresponding author)
  29. Lin GM*, Li YH, Chu KM, Han CL. Controversies with On-TIME 2. Heart. 2011;97(12):1026 (SCI, *corresponding author)
  30. Lin GM*, Li YH, Chu KM, Han CL. Malnutrition and hyponatremia in dialysis patients. Am J Med. 2011;124(8):e21 (SCI, *corresponding author)
  31. Lin GM*, Li YH, Chu KM, Han CL. Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention. Heart. 2011;97(13):1111 (SCI, *corresponding author)
  32. Lin GM*. Anticoagulation in patients with stroke with infective endocarditis. Int J Cardiol. 2011;151(2):246. (SCI, *corresponding author)
  33. Lin GM*.. C-reactive protein, smoking and the metabolic syndrome. Int J Cardiol. 2011;151(3):373-4. (SCI, *corresponding author)
  34. Lin GM*, Li YH, Chu KM, Han CL. Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry. Am Heart J. 2011;162(1):e17 (SCI, *corresponding author)
  35. Lin TY, Wu SW, Lin GM, Chen YG. Hidden Diagnosis of Tuberculous Pleurisy Masked by Concomitant Pseudomonas oryzihabitans Bacteremia. Respir Care. 2011 Jul 12. [Epub ahead of print]
  36. Lin GM*, Li YH, Han CL. A critical appraisal of pexelizumab treatment in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;142(2):472 (SCI, *corresponding author)
  37. Lin GM*, Li YH. Hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med. 2011;155(3):202 (SCI, *corresponding author)